Alliancebernstein L.P. United Therapeutics Corp Transaction History

Alliancebernstein L.P.

  • $275 Billion
  • Q1 2024

A detailed history of Alliancebernstein L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 473,285 shares of UTHR stock, worth $130 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
473,285
Previous 104,155 354.4%
Holding current value
$130 Million
Previous $22.9 Million 374.73%
% of portfolio
0.04%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$210.76 - $249.51 $77.8 Million - $92.1 Million
369,130 Added 354.4%
473,285 $109 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $2.66 Million - $3.18 Million
12,370 Added 13.48%
104,155 $22.9 Million
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $2.34 Million - $2.75 Million
11,068 Added 13.71%
91,785 $20.7 Million
Q2 2023

Aug 15, 2023
BUY
$205.19 - $232.99 $2.16 Million - $2.46 Million
10,544 Added 15.03%
80,717 $17.8 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $351,646 - $455,956
1,651 Added 2.41%
70,173 $15.7 Million
Q4 2022

Feb 14, 2023
BUY
$205.95 - $280.43 $14,828 - $20,190
72 Added 0.11%
68,522 $19.1 Million
Q3 2022

Nov 15, 2022
SELL
$203.3 - $244.17 $11.5 Million - $13.8 Million
-56,601 Reduced 45.26%
68,450 $14.3 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $7 Million - $9.65 Million
40,025 Added 47.07%
125,051 $29.5 Million
Q1 2022

May 13, 2022
SELL
$166.16 - $213.96 $1.16 Million - $1.49 Million
-6,968 Reduced 7.57%
85,026 $15.3 Million
Q4 2021

Feb 14, 2022
BUY
$184.32 - $216.08 $3.98 Million - $4.66 Million
21,581 Added 30.65%
91,994 $19.9 Million
Q3 2021

Nov 10, 2021
SELL
$179.86 - $214.88 $182,018 - $217,458
-1,012 Reduced 1.42%
70,413 $13 Million
Q2 2021

Jul 30, 2021
SELL
$170.47 - $211.93 $186,153 - $231,427
-1,092 Reduced 1.51%
71,425 $12.8 Million
Q1 2021

May 06, 2021
SELL
$153.94 - $174.85 $2.39 Million - $2.72 Million
-15,542 Reduced 17.65%
72,517 $12.1 Million
Q4 2020

Feb 08, 2021
SELL
$101.87 - $151.79 $34,737 - $51,760
-341 Reduced 0.39%
88,059 $13.4 Million
Q3 2020

Nov 12, 2020
SELL
$99.9 - $121.13 $590,708 - $716,241
-5,913 Reduced 6.27%
88,400 $8.93 Million
Q2 2020

Aug 13, 2020
BUY
$92.74 - $125.82 $1.8 Million - $2.44 Million
19,392 Added 25.88%
94,313 $11.4 Million
Q1 2020

May 14, 2020
SELL
$79.39 - $115.35 $31,597 - $45,909
-398 Reduced 0.53%
74,921 $7.1 Million
Q4 2019

Feb 18, 2020
BUY
$78.31 - $95.34 $185,594 - $225,955
2,370 Added 3.25%
75,319 $6.63 Million
Q3 2019

Nov 14, 2019
SELL
$74.85 - $85.99 $84,954 - $97,598
-1,135 Reduced 1.53%
72,949 $5.82 Million
Q2 2019

Aug 14, 2019
SELL
$76.06 - $120.81 $1.05 Million - $1.67 Million
-13,804 Reduced 15.71%
74,084 $5.78 Million
Q1 2019

May 14, 2019
SELL
$107.15 - $126.84 $3.7 Million - $4.38 Million
-34,507 Reduced 28.19%
87,888 $10.3 Million
Q4 2018

Feb 13, 2019
BUY
$101.4 - $128.73 $4.56 Million - $5.79 Million
44,960 Added 58.06%
122,395 $13.3 Million
Q3 2018

Nov 08, 2018
BUY
$113.81 - $129.46 $3.16 Million - $3.59 Million
27,729 Added 55.79%
77,435 $9.9 Million
Q2 2018

Aug 13, 2018
BUY
$101.14 - $118.31 $541,604 - $633,550
5,355 Added 12.07%
49,706 $5.62 Million
Q1 2018

May 14, 2018
SELL
$107.21 - $151.94 $147,949 - $209,677
-1,380 Reduced 3.02%
44,351 $4.98 Million
Q4 2017

Feb 13, 2018
SELL
$118.58 - $151.28 $150,003 - $191,369
-1,265 Reduced 2.69%
45,731 $6.77 Million
Q3 2017

Nov 13, 2017
BUY
$114.6 - $136.81 $5.39 Million - $6.43 Million
46,996
46,996 $5.51 Million

Others Institutions Holding UTHR

# of Institutions
562
Shares Held
43.1M
Call Options Held
501K
Put Options Held
529K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $12.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email